Telisa 80 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Telmisartan |
| Company | Acme laboratories ltd |
| Also available as |
Product Title
- Telisa Tablets
Categories
- Medicines
- Hypertension Management
- Cardiovascular Risk Reduction
Description
Telisa tablets contain Telmisartan, a non-peptide angiotensin-ll receptor antagonist, indicated for the treatment of essential hypertension in adults and reduction of cardiovascular morbidity in adults with atherothrombotic cardiovascular disease or type 2 diabetes mellitus with documented target organ damage. Telmisartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin-ll by selectively blocking its binding to the AT1 receptor.
Dimension
Standard tablet size
Color Options
- White
- Off-white
Dosage Form
Tablets
Dosage Strengths
- 20 mg
- 40 mg
- 80 mg
Administration Frequency
Once daily
Blood Pressure Response Time
Apparent within 2 weeks
Maximal Blood Pressure Reduction Time
Generally attained after 4 weeks
Special Population Considerations
- Elderly patients
- Patients with renal impairment
- Patients on hemodialysis
- Pediatric patients
- Geriatric patients
- Patients with hepatic impairment
Pediatric Use Safety
Not established
Geriatric Use Safety
No overall differences observed
Hepatic Impairment Monitoring
Careful monitoring and slow up-titration
Interaction with NSAIDs
Increases risk of renal impairment and loss of antihypertensive effect
Interaction with Aliskiren in Diabetes Patients
Should be avoided
Contraindications
- Known hypersensitivity to Telmisartan or any of its components
Common Side Effects in Hypertensive Patients
- Sinus pain and congestion (sinusitis)
- Back pain
- Diarrhea
Common Side Effects in Cardiovascular Risk Reduction Patients
- Intermittent claudication
- Skin ulcer
Pregnancy Category
- Category C (first trimester)
- Category D (second and third trimester)
Lactation Consideration
Potential for adverse effects on the nursing infant
Precautions & Warnings
- Avoid fetal or neonatal exposure
- Hypotension
- Monitor carefully in impaired hepatic or renal function
- Avoid concomitant use of an ACE inhibitor and angiotensin receptor blocker
Overdose Effects
- Hypotension
- Dizziness
- Tachycardia
- Bradycardia
- Increase in serum creatinine
- Acute renal failure
Therapeutic Class
Angiotensin-ll receptor blocker
Storage Conditions
- Do not store above 30°C
- Protect from light and high humidity
- Keep out of the reach of children